Meet Pharmidex at KTN 2016
June 14, 2016

Collaboration opportunities in regenerative medicine

Pharmdiex will be attending the Innvoate UK KTN 2016 meeting focused on New Collaboration Opportunities in Regenerative Medicine.

The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event focussing on new unmet clinical needs, latest developments in regulatory environment and clinical adoption. Following recent developments and the UK’s Regenerative Medicine Expert Group report recommendations, this event will bring together the UK regenerative medicine communities involving industrialists, academics and clinicians from a number of clinical specialities.


The UK is leading the field in the development of cell and gene therapies. The regulatory system now has a number of mechanisms to accelerate the progress of promising therapies including EAMS and the proposed new PRIME scheme. However, practical challenges still exist to the clinical adoption of these new therapies and getting them to patients, including generating sufficient clinical data, achieving reimbursement and embedding therapies in existing or new clinical pathways).


Leading clinicians and experts from a number of organisations will be presenting at this event. Directors and managers from major funding organisations, e.g. Innovate UK, Research Councils, relevant charities will also be invited to support this event.


The main aims of this event are as follows;


  • To discuss challenges affecting clinical adoption of cell and gene-based therapies.
  • Facilitate new clinician/industry collaborations in a number of areas of clinical specialities.
  • Identify barriers to innovation and commercialisation.
  • Review current funding opportunities and identify funding gaps.
  • Provide networking opportunities to identify collaborating partners.
  • Review supporting mechanisms available to accelerate innovation and commercialisation through KTN and partners Innovate UK, Cell and Gene Therapy Catapult organisations.
  • Review current pre-clinical and clinical trials and identify best practice to accelerate regulatory approvals


For more information please see the following link: https://www.eventbrite.co.uk/e/new-collaboration-opportunities-in-regenerative-medicine-tickets-24454460951

August 4, 2025
At Pharmidex , we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration. ๐Ÿ“ Scientist-Led from Start to Finish Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution. ๐Ÿค Connected Teams, Coordinated Delivery From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication. ๐Ÿงช Agile, High-Quality Science We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency. ๐Ÿงญ We’re Not Just a CRO, We’re Your Partner We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission. Let’s partner on your next breakthrough. ๐Ÿ“ง Contact us today.
Weโ€™re Hiring! Senior/Principal Scientistโ€“In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. ๐Ÿ‘ฉ‍๐Ÿ”ฌ ๐Ÿ‘จ‍๐Ÿ”ฌ Welcome to the team, Gabrielle and Mohammed!
More Posts